Lumigan 0.03% EyeDrop

Uses of Lumigan 0.03% EyeDrop

Bimatoprost used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension.

Side Effects of Lumigan 0.03% EyeDrop

Ocular irritation, conjunctival hyperaemia, transient punctate epithelial erosions and eyelid oedema. Darkening and thickening of the eye lashes may occur.

Drug Interactions

NA

Contraindications

NA

Mechanism of Action

Bimatoprost is a prostamide analogue with ocular hypotensive action. It is postulated to lower intraocular pressure by increasing outflow of aqueous humor through both the trabecular meshwork and uveoscleral routes. Absorption: Serum concentrations peak within 10 minutes of dosing. Distribution: Moderately distributed into body tissues. Metabolism: Undergoes oxidation, de-ethylation and glucuronidation. Excretion: 67% is excreted in the urine and 25% in the faeces. Elimination half-life: About 45 minutes.

Special Precautions

May increase pigmentation of the iris, periorbital tissue and eyelashes. Active intraocular inflammation. Safety and efficacy have not been evaluated in the treatment of inflammatory, neovascular or angle closure glaucoma. Ensure at least an interval of 5 minutes between admin of ophthalmic preparations. Contact lenses should be removed prior to admin. Pregnancy, lactation.

How to Use

Take orally with food and water, as directed by your physician.

How to Store

Keep in a cool, dry place away from sunlight and moisture.

Safety Concerns

• Alcohol: Avoid during treatment.
• Breastfeeding: Not recommended.
• Pregnancy: Contraindicated.
• Liver/Kidney: Use with caution.

Content Disclaimer

This content is for educational purposes only. Please consult your doctor before use.